Receptor-selective retinoid and rexinoid compounds and immunomodulators for cancer immunotherapy

摘要

Disclosed herein is a method for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one retinoic acid receptor or retinoid X receptor activator. [Selected figure] Figure 1A